Khosla Impact

Khosla Impact, established in 2013, is an impact investment firm based in Menlo Park, California. It focuses on assisting high-impact entrepreneurs who develop products and services for the three billion people at the bottom of the world's economic pyramid. The firm invests in for-profit enterprises serving low-income individuals and small businesses in emerging markets, with a primary focus on South Asia. Khosla Impact encourages experimentation and supports entrepreneurs passionate about solving socio-economic challenges through technology and innovative business models.

Alex Bentley

Partner and Investor

Ryno Blignaut

Operating Partner

Alice Brooks

Principal

Peter Buckland

General Partner and COO

Brian Byun

Venture Partner

Catherine Casuga

Operating Partner

Bryan Gartner

Partner

Kanu Gulati

Partner

Judy Huang

Operating Partner

Jun Jeon

Principal

Samir Kaul

Founding Partner and Managing Director

Vinod Khosla

Managing Director

Kelly Kinnard

Operating Partner

Evan Moore

Partner

Alexander Morgan

Partner

Nicholas Moryl

Associate

Keith Rabois

Managing Director

Arash Rebek

Partner, Capital Formation

Jessy Rivest

Partner and Investor

Jai Sajnani

Partner

Jai Sajnani

Partner and Investor

Leah Scanlan

Operating Partner

Nikita Shamgunov

Partner

Sven Strohband

Managing Director

Rajesh Swaminathan

Partner

David Weiden

Managing Director

Reze Wong

Partner

Adam Coates

Operating Partner

Kanupriya Gulati Ph.D

Partner and Investor

Past deals in New England

Ramp

Secondary Market in 2025
Ramp Holdings, Inc. specializes in Software-as-a-Service solutions aimed at modernizing financial operations and enhancing content delivery. The company provides a comprehensive platform that includes tools for corporate card management, expense tracking, bill payments, and accounting integrations. By leveraging advanced technologies such as speech-to-text, natural language processing, and search engine optimization, Ramp allows organizations to maximize the value of their video content and drive increased engagement. Its offerings also include various video management solutions, notably for the SharePoint ecosystem, which facilitate seamless integration, live streaming, and efficient content delivery. Founded in 1948 and based in Boston, Massachusetts, Ramp operates as a subsidiary of Raytheon BBN Technologies Corporation. The company serves diverse industries, including media, finance, healthcare, and technology, with a focus on creating cost-effective and insightful financial tools for organizations.

Egenesis

Series D in 2024
Egenesis Inc. is a biotechnology company focused on gene editing and genome engineering to create human transplantable organs, tissues, and cells. Established in 2015 and headquartered in Cambridge, Massachusetts, with an additional office in New York City, Egenesis aims to address the global organ shortage by developing solid organs and therapeutic cell transplantation solutions for various diseases. The company utilizes a gene editing platform that incorporates techniques such as single-cell cloning and somatic cell nuclear transfer, which are essential for creating human-compatible organ tissues and cells. Egenesis is particularly engaged in advancing programs related to kidney and islet cell transplantation, striving to provide alternative treatment options for patients with life-threatening conditions.

Ramp

Series D in 2024
Ramp Holdings, Inc. specializes in Software-as-a-Service solutions aimed at modernizing financial operations and enhancing content delivery. The company provides a comprehensive platform that includes tools for corporate card management, expense tracking, bill payments, and accounting integrations. By leveraging advanced technologies such as speech-to-text, natural language processing, and search engine optimization, Ramp allows organizations to maximize the value of their video content and drive increased engagement. Its offerings also include various video management solutions, notably for the SharePoint ecosystem, which facilitate seamless integration, live streaming, and efficient content delivery. Founded in 1948 and based in Boston, Massachusetts, Ramp operates as a subsidiary of Raytheon BBN Technologies Corporation. The company serves diverse industries, including media, finance, healthcare, and technology, with a focus on creating cost-effective and insightful financial tools for organizations.

Reflex Robotics

Seed Round in 2023
Reflex Robotics specializes in developing affordable humanoid robots, priced at around $10,000, to automate hazardous and repetitive tasks in logistics and manufacturing sectors. Their robots are designed and manufactured in-house by a team that previously led the development of the Stretch robot at Boston Dynamics and key components of Tesla's Model S, X, and Y production lines. The company's robotic technology is currently employed in beverage packing, warehouse palletizing, and shelf tote picking, aiming to streamline daily operations for various industries.

Volta Labs

Series A in 2022
Volta Labs, Inc. is a biotechnology company based in Cambridge, Massachusetts, founded in 2018. The company specializes in developing tools for biological automation, focusing on scalable automation solutions for genetic engineering. Volta Labs operates a platform designed for affordable genomic sample preparation, aimed at revolutionizing genomics research. This platform leverages automation and miniaturization technologies to streamline the creation of biological samples. By integrating expertise from engineering, surface chemistry, and molecular biology, Volta Labs enables biotech organizations to automate complex biological workflows, facilitating advancements in genomics and genetic engineering.

Scipher Medicine

Series D in 2022
Scipher Medicine Corporation is a biotechnology company based in Waltham, Massachusetts, that specializes in precision medicine for patients with autoimmune and cardiovascular diseases. The company has developed a molecular technology platform that utilizes blood samples to analyze RNA and predict patient responses to drug therapies. Its primary offerings include PrismDx tests, which identify patients who may not respond to certain medications, ensuring they can be prescribed alternative treatments. Notably, the PrismRA test assesses patients with rheumatoid arthritis to determine their likelihood of responding to anti-TNF therapies, while PrismUC serves a similar purpose for patients with ulcerative colitis. By focusing on the underlying disease biology rather than just symptoms, Scipher Medicine aims to optimize treatment from the outset, potentially reducing the healthcare costs associated with ineffective therapies. Established in 2013 and rebranded in 2015, Scipher Medicine is committed to transforming drug prescription practices and advancing drug development through its innovative approach.

Vicarious Surgical

Post in 2021
Vicarious Surgical Inc. is a robotics company based in Charlestown, Massachusetts, established in 2014. The company focuses on developing advanced robotic systems that enhance the efficiency of minimally invasive surgical procedures. Its innovative surgical robot combines virtual reality with human-like robotics, allowing for greater precision and control during complex surgeries. Designed for abdominal access, the Vicarious Surgical Robotic System features 3D visualization and operates through a single port, which minimizes invasiveness and promotes faster patient recovery. This compact and portable system can be easily integrated into existing operating rooms, aiming to improve patient outcomes and reduce healthcare costs.

SingleStore

Series F in 2021
SingleStore, Inc. is a provider of a relational database designed for cloud and on-premises transactions and analytics, catering to global enterprises. Founded in 2011 and headquartered in San Francisco, California, the company offers the SingleStore Managed Service, a cloud database-as-a-service that enables analytics on various cloud platforms, alongside SingleStore DB, a distributed SQL database suitable for both bare metal and hybrid cloud environments. The company focuses on operational analytics and supports modern data platform solutions that encompass IoT analytics, risk management, and customer engagement. SingleStore serves a diverse range of industries, including financial services, media communications, energy and utilities, government, and retail. The company, previously known as MemSQL Inc., rebranded to SingleStore, Inc. in October 2020 and also maintains offices in Seattle, Boston, Portland, Lisbon, and London.

Scipher Medicine

Series C in 2021
Scipher Medicine Corporation is a biotechnology company based in Waltham, Massachusetts, that specializes in precision medicine for patients with autoimmune and cardiovascular diseases. The company has developed a molecular technology platform that utilizes blood samples to analyze RNA and predict patient responses to drug therapies. Its primary offerings include PrismDx tests, which identify patients who may not respond to certain medications, ensuring they can be prescribed alternative treatments. Notably, the PrismRA test assesses patients with rheumatoid arthritis to determine their likelihood of responding to anti-TNF therapies, while PrismUC serves a similar purpose for patients with ulcerative colitis. By focusing on the underlying disease biology rather than just symptoms, Scipher Medicine aims to optimize treatment from the outset, potentially reducing the healthcare costs associated with ineffective therapies. Established in 2013 and rebranded in 2015, Scipher Medicine is committed to transforming drug prescription practices and advancing drug development through its innovative approach.

Egenesis

Series C in 2021
Egenesis Inc. is a biotechnology company focused on gene editing and genome engineering to create human transplantable organs, tissues, and cells. Established in 2015 and headquartered in Cambridge, Massachusetts, with an additional office in New York City, Egenesis aims to address the global organ shortage by developing solid organs and therapeutic cell transplantation solutions for various diseases. The company utilizes a gene editing platform that incorporates techniques such as single-cell cloning and somatic cell nuclear transfer, which are essential for creating human-compatible organ tissues and cells. Egenesis is particularly engaged in advancing programs related to kidney and islet cell transplantation, striving to provide alternative treatment options for patients with life-threatening conditions.

Vicarious Surgical

Series A in 2020
Vicarious Surgical Inc. is a robotics company based in Charlestown, Massachusetts, established in 2014. The company focuses on developing advanced robotic systems that enhance the efficiency of minimally invasive surgical procedures. Its innovative surgical robot combines virtual reality with human-like robotics, allowing for greater precision and control during complex surgeries. Designed for abdominal access, the Vicarious Surgical Robotic System features 3D visualization and operates through a single port, which minimizes invasiveness and promotes faster patient recovery. This compact and portable system can be easily integrated into existing operating rooms, aiming to improve patient outcomes and reduce healthcare costs.

Commonwealth Fusion Systems

Series A in 2020
Commonwealth Fusion Systems LLC is a research and development company focused on advancing fusion energy technology to provide an inexhaustible power source. Established in 2017 and based in Cambridge, Massachusetts, the company utilizes rare-earth barium copper oxide superconductor technology to create fusion energy systems. Commonwealth Fusion Systems was spun out of the Massachusetts Institute of Technology (MIT) and collaborates with MIT’s Plasma Science and Fusion Center to leverage decades of government-funded fusion research. By integrating established physics with innovative magnet technology, the company aims to accelerate the commercialization of fusion energy, positioning itself as a key player in the transition to clean and renewable energy sources while addressing climate change challenges.

E25Bio

Venture Round in 2020
E25Bio Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing rapid diagnostic tests for epidemic fever viruses, including dengue, chikungunya, and Zika. Founded in 2018, the company specializes in paper-based diagnostic systems that enable swift detection of viral antigens produced during infections. Its innovative platform allows for real-time data reporting through a mobile application, which captures results along with information on test timing and location. This approach aims to facilitate epidemiologic predictions and disease mapping, ultimately assisting governments and health organizations in managing outbreaks effectively and preventing public health crises. E25Bio's solutions are designed to provide affordable and timely diagnostics at the point of care.

Iora Health

Series F in 2020
Iora Health, Inc. is a healthcare provider based in Boston, Massachusetts, established in 2010. The company specializes in primary care services, focusing on delivering personalized and relationship-based care to patients across the United States. Each patient is assigned a dedicated physician and a health coach, who maintain regular communication through various channels, including email, text, and video. Iora Health employs a team-based approach that includes physicians, nurse practitioners, nurses, behavioral health specialists, and health coaches, all supported by a proprietary technology platform that enhances population health management. The organization also offers educational programs, such as group visits, to help patients achieve their health goals and navigate the healthcare system without barriers.

Egenesis

Series B in 2019
Egenesis Inc. is a biotechnology company focused on gene editing and genome engineering to create human transplantable organs, tissues, and cells. Established in 2015 and headquartered in Cambridge, Massachusetts, with an additional office in New York City, Egenesis aims to address the global organ shortage by developing solid organs and therapeutic cell transplantation solutions for various diseases. The company utilizes a gene editing platform that incorporates techniques such as single-cell cloning and somatic cell nuclear transfer, which are essential for creating human-compatible organ tissues and cells. Egenesis is particularly engaged in advancing programs related to kidney and islet cell transplantation, striving to provide alternative treatment options for patients with life-threatening conditions.

Commonwealth Fusion Systems

Series A in 2019
Commonwealth Fusion Systems LLC is a research and development company focused on advancing fusion energy technology to provide an inexhaustible power source. Established in 2017 and based in Cambridge, Massachusetts, the company utilizes rare-earth barium copper oxide superconductor technology to create fusion energy systems. Commonwealth Fusion Systems was spun out of the Massachusetts Institute of Technology (MIT) and collaborates with MIT’s Plasma Science and Fusion Center to leverage decades of government-funded fusion research. By integrating established physics with innovative magnet technology, the company aims to accelerate the commercialization of fusion energy, positioning itself as a key player in the transition to clean and renewable energy sources while addressing climate change challenges.

Vicarious Surgical

Series B in 2019
Vicarious Surgical Inc. is a robotics company based in Charlestown, Massachusetts, established in 2014. The company focuses on developing advanced robotic systems that enhance the efficiency of minimally invasive surgical procedures. Its innovative surgical robot combines virtual reality with human-like robotics, allowing for greater precision and control during complex surgeries. Designed for abdominal access, the Vicarious Surgical Robotic System features 3D visualization and operates through a single port, which minimizes invasiveness and promotes faster patient recovery. This compact and portable system can be easily integrated into existing operating rooms, aiming to improve patient outcomes and reduce healthcare costs.

Nebula Genomics

Series A in 2018
Nebula Genomics is a company that focuses on human genome sequencing and health data, aiming to create a comprehensive online marketplace for genomic information. Founded in 2016 by Harvard genomics pioneer George Church and his colleagues, the company is headquartered in San Francisco, California, with additional offices in Boston, Massachusetts. Nebula Genomics utilizes blockchain technology to empower consumers by allowing them to maintain control over their genomic data and receive compensation for its use. The platform aggregates extensive genetic information, enabling researchers to analyze data for accelerated drug development and personalized medicine. The company’s DNA sequencing technology covers all genes, regulatory regions, the Y chromosome, and mitochondrial DNA, facilitating in-depth genetic analysis and variant exploration.

Scipher Medicine

Series A in 2018
Scipher Medicine Corporation is a biotechnology company based in Waltham, Massachusetts, that specializes in precision medicine for patients with autoimmune and cardiovascular diseases. The company has developed a molecular technology platform that utilizes blood samples to analyze RNA and predict patient responses to drug therapies. Its primary offerings include PrismDx tests, which identify patients who may not respond to certain medications, ensuring they can be prescribed alternative treatments. Notably, the PrismRA test assesses patients with rheumatoid arthritis to determine their likelihood of responding to anti-TNF therapies, while PrismUC serves a similar purpose for patients with ulcerative colitis. By focusing on the underlying disease biology rather than just symptoms, Scipher Medicine aims to optimize treatment from the outset, potentially reducing the healthcare costs associated with ineffective therapies. Established in 2013 and rebranded in 2015, Scipher Medicine is committed to transforming drug prescription practices and advancing drug development through its innovative approach.

Digital Alloys

Series B in 2018
Digital Alloys, Inc. is a company based in Burlington, Massachusetts, that specializes in the development and manufacturing of advanced metal 3-D printers. Founded in 2017 as a spinout from New Valence Robotics, the company focuses on high-speed, multi-metal additive manufacturing systems capable of producing production-quality parts from various metals at a significantly lower cost than traditional methods. Its patented technology utilizes commodity wire as the raw material, allowing for a simpler and faster process for melting wire into useful shapes. This innovative approach enables manufacturers to mix multiple metals within a single part, enhancing design possibilities and optimizing the thermal, electrical, magnetic, and mechanical properties of the products created. Digital Alloys aims to make metal 3D printing more accessible for a wider range of applications.

Ten Percent Happier

Seed Round in 2018
Ten Percent Happier, Inc. is a Boston-based company that offers a meditation platform aimed at individuals who may be skeptical about traditional meditation practices. Founded in 2013, the company provides a mobile application that facilitates learning, practicing, and tracking meditation behaviors. The platform features expert-led courses, articles, and podcasts designed to foster meaningful changes in users' lives. Additionally, Ten Percent Happier publishes books that contain practical instructions for meditation, ensuring accessibility for a diverse audience. The company focuses on delivering a clear and straightforward approach to meditation, combining various multimedia resources to engage users effectively.

Iora Health

Series E in 2018
Iora Health, Inc. is a healthcare provider based in Boston, Massachusetts, established in 2010. The company specializes in primary care services, focusing on delivering personalized and relationship-based care to patients across the United States. Each patient is assigned a dedicated physician and a health coach, who maintain regular communication through various channels, including email, text, and video. Iora Health employs a team-based approach that includes physicians, nurse practitioners, nurses, behavioral health specialists, and health coaches, all supported by a proprietary technology platform that enhances population health management. The organization also offers educational programs, such as group visits, to help patients achieve their health goals and navigate the healthcare system without barriers.

Vicarious Surgical

Series A in 2018
Vicarious Surgical Inc. is a robotics company based in Charlestown, Massachusetts, established in 2014. The company focuses on developing advanced robotic systems that enhance the efficiency of minimally invasive surgical procedures. Its innovative surgical robot combines virtual reality with human-like robotics, allowing for greater precision and control during complex surgeries. Designed for abdominal access, the Vicarious Surgical Robotic System features 3D visualization and operates through a single port, which minimizes invasiveness and promotes faster patient recovery. This compact and portable system can be easily integrated into existing operating rooms, aiming to improve patient outcomes and reduce healthcare costs.

Mainspring

Series C in 2017
Mainspring designs and develops digital business strategies. The company provides consulting services focusing on digital technologies, business optimization, and technology enablement. Mainspring, formerly known as Mainspring Communications Inc., was founded in 1996 and is based in Cambridge, Massachusetts.

Twine Health

Series A in 2017
Twine Health, Inc. is a healthcare technology company that specializes in a cloud-based platform aimed at chronic disease management. The platform facilitates collaborative care by integrating tools for shared decision-making, self-tracking, and communication between patients and their healthcare providers. Patients can co-create personalized care plans with their care teams, which may include physicians, nurses, family members, and health coaches. This collaborative approach is designed to enhance patient engagement and self-efficacy, ultimately leading to better health outcomes and reduced healthcare costs. Established in 2012 and based in Cambridge, Massachusetts, Twine Health was developed at the MIT Medical Lab and operates as a subsidiary of Fitbit, Inc. since 2018.

Egenesis

Series A in 2017
Egenesis Inc. is a biotechnology company focused on gene editing and genome engineering to create human transplantable organs, tissues, and cells. Established in 2015 and headquartered in Cambridge, Massachusetts, with an additional office in New York City, Egenesis aims to address the global organ shortage by developing solid organs and therapeutic cell transplantation solutions for various diseases. The company utilizes a gene editing platform that incorporates techniques such as single-cell cloning and somatic cell nuclear transfer, which are essential for creating human-compatible organ tissues and cells. Egenesis is particularly engaged in advancing programs related to kidney and islet cell transplantation, striving to provide alternative treatment options for patients with life-threatening conditions.

Digital Alloys

Series A in 2017
Digital Alloys, Inc. is a company based in Burlington, Massachusetts, that specializes in the development and manufacturing of advanced metal 3-D printers. Founded in 2017 as a spinout from New Valence Robotics, the company focuses on high-speed, multi-metal additive manufacturing systems capable of producing production-quality parts from various metals at a significantly lower cost than traditional methods. Its patented technology utilizes commodity wire as the raw material, allowing for a simpler and faster process for melting wire into useful shapes. This innovative approach enables manufacturers to mix multiple metals within a single part, enhancing design possibilities and optimizing the thermal, electrical, magnetic, and mechanical properties of the products created. Digital Alloys aims to make metal 3D printing more accessible for a wider range of applications.

Vicarious Surgical

Venture Round in 2016
Vicarious Surgical Inc. is a robotics company based in Charlestown, Massachusetts, established in 2014. The company focuses on developing advanced robotic systems that enhance the efficiency of minimally invasive surgical procedures. Its innovative surgical robot combines virtual reality with human-like robotics, allowing for greater precision and control during complex surgeries. Designed for abdominal access, the Vicarious Surgical Robotic System features 3D visualization and operates through a single port, which minimizes invasiveness and promotes faster patient recovery. This compact and portable system can be easily integrated into existing operating rooms, aiming to improve patient outcomes and reduce healthcare costs.

Iora Health

Series D in 2016
Iora Health, Inc. is a healthcare provider based in Boston, Massachusetts, established in 2010. The company specializes in primary care services, focusing on delivering personalized and relationship-based care to patients across the United States. Each patient is assigned a dedicated physician and a health coach, who maintain regular communication through various channels, including email, text, and video. Iora Health employs a team-based approach that includes physicians, nurse practitioners, nurses, behavioral health specialists, and health coaches, all supported by a proprietary technology platform that enhances population health management. The organization also offers educational programs, such as group visits, to help patients achieve their health goals and navigate the healthcare system without barriers.

SingleStore

Series C in 2016
SingleStore, Inc. is a provider of a relational database designed for cloud and on-premises transactions and analytics, catering to global enterprises. Founded in 2011 and headquartered in San Francisco, California, the company offers the SingleStore Managed Service, a cloud database-as-a-service that enables analytics on various cloud platforms, alongside SingleStore DB, a distributed SQL database suitable for both bare metal and hybrid cloud environments. The company focuses on operational analytics and supports modern data platform solutions that encompass IoT analytics, risk management, and customer engagement. SingleStore serves a diverse range of industries, including financial services, media communications, energy and utilities, government, and retail. The company, previously known as MemSQL Inc., rebranded to SingleStore, Inc. in October 2020 and also maintains offices in Seattle, Boston, Portland, Lisbon, and London.

Twine Health

Series A in 2015
Twine Health, Inc. is a healthcare technology company that specializes in a cloud-based platform aimed at chronic disease management. The platform facilitates collaborative care by integrating tools for shared decision-making, self-tracking, and communication between patients and their healthcare providers. Patients can co-create personalized care plans with their care teams, which may include physicians, nurses, family members, and health coaches. This collaborative approach is designed to enhance patient engagement and self-efficacy, ultimately leading to better health outcomes and reduced healthcare costs. Established in 2012 and based in Cambridge, Massachusetts, Twine Health was developed at the MIT Medical Lab and operates as a subsidiary of Fitbit, Inc. since 2018.

Editas Medicine

Series B in 2015
Editas Medicine is a clinical-stage biotechnology company based in Cambridge, Massachusetts, with an additional site in Boulder, Colorado. Founded in 2013, the company focuses on the discovery and development of genome editing therapeutics, primarily utilizing its proprietary CRISPR/Cas9 technology. This innovative platform enables precise molecular modifications at the genetic level, with the aim of treating a wide array of serious diseases by addressing their underlying causes. Editas Medicine has established a strong intellectual property portfolio, which includes numerous patents related to foundational genome editing technologies and advancements that facilitate the translation of research into viable human therapeutics. The company's mission is to pioneer transformative genomic medicines that can significantly improve patient outcomes across various genetic disorders.

SES

Series B in 2015
SolidEnergy Systems Corp. develops and manufactures rechargeable lithium metal batteries primarily for applications in drones, wearables, smartphones, and electric vehicles. Founded in 2012 and based in Woburn, Massachusetts, the company focuses on producing high-performance lithium metal batteries and supplying essential materials, such as anodes and electrolytes, to major lithium-ion cell manufacturers. These materials can be integrated into existing manufacturing processes, allowing for scalability without significant infrastructure investments. SolidEnergy's pilot-scale production caters to prototype demonstrations and specialized aerospace markets, while its future growth is aimed at mainstream sectors like consumer electronics and electric vehicles. Additionally, the company is involved in developing AI-powered safety algorithms and recycling solutions, positioning itself as an integrated battery manufacturer with a commitment to innovation and sustainability.

Iora Health

Series C in 2015
Iora Health, Inc. is a healthcare provider based in Boston, Massachusetts, established in 2010. The company specializes in primary care services, focusing on delivering personalized and relationship-based care to patients across the United States. Each patient is assigned a dedicated physician and a health coach, who maintain regular communication through various channels, including email, text, and video. Iora Health employs a team-based approach that includes physicians, nurse practitioners, nurses, behavioral health specialists, and health coaches, all supported by a proprietary technology platform that enhances population health management. The organization also offers educational programs, such as group visits, to help patients achieve their health goals and navigate the healthcare system without barriers.

Quantopian

Series B in 2014
Quantopian, Inc. operates an online platform designed for the development and testing of quantitative trading algorithms. Founded in 2011 and based in Boston, Massachusetts, the platform offers tools and infrastructure that allow users to learn about quantitative finance, engage in community discussions, and explore algorithms shared by other members. Users can create and backtest their algorithms, review performance results and risk metrics, and trade their strategies. The company boasts a community of approximately 195,000 quants who collaborate and share insights. Additionally, select algorithm authors can license their algorithms to Quantopian, earning compensation based on performance. The firm provides capital, data, and resources to support its community in researching, coding, and executing algorithmic investing strategies.

Lookout

Series F in 2014
Lookout, Inc. is a cybersecurity company specializing in cloud-based technology solutions for mobile security. Founded in 2005 and headquartered in San Francisco, California, with additional offices in major cities worldwide, Lookout offers a range of products including mobile security apps for both Android and iOS devices. Its solutions encompass Mobile Threat Protection, a Mobile Intelligence Center for real-time threat investigations, and an App Vetting API designed to secure enterprise and commercial app stores. By providing organizations with tools to enable bring-your-own-device (BYOD) policies, ensure compliance, and combat advanced mobile threats, Lookout empowers enterprises and individuals to safeguard their sensitive data across devices, applications, networks, and clouds. The company's platform is trusted by various enterprises, government agencies, and millions of consumers, allowing them to manage their data securely and efficiently.

EyeNetra

Series A in 2014
EyeNetra, Inc. is a company that specializes in the development and manufacturing of eye diagnostics technology, including auto-refractors and lens-meters. Founded in 2011 and based in Somerville, Massachusetts, EyeNetra's platform allows users to conduct their own eye tests using smartphone-based technology. This innovative approach enables individuals to measure their refractive errors, such as nearsightedness, farsightedness, and astigmatism, while also providing eye care professionals with accurate diagnostic measurements for prescribing corrective lenses. The company's flagship products, including the NETRA autorefractor and lensometer, facilitate a straightforward and efficient testing process. Additionally, EyeNetra offers the Insight Portal, which enhances electronic medical record management and supports mobile clinics in delivering eye care services globally.

Ambri

Series C in 2014
Ambri, Inc. is a company based in Marlborough, Massachusetts, focused on developing innovative electricity storage solutions through its liquid metal battery technology. Founded in 2010 and originally known as Liquid Metal Battery Corporation, Ambri aims to revolutionize grid-scale power storage by offering batteries that are low-cost, long-lasting, and capable of storing significant amounts of energy. These batteries are particularly suited for applications in renewable energy systems and grid stabilization. Ambri's technology is designed to enhance the reliability and efficiency of energy storage, with systems that can tolerate short circuits and other operational challenges, making them a robust choice for grid operators.

SingleStore

Series B in 2014
SingleStore, Inc. is a provider of a relational database designed for cloud and on-premises transactions and analytics, catering to global enterprises. Founded in 2011 and headquartered in San Francisco, California, the company offers the SingleStore Managed Service, a cloud database-as-a-service that enables analytics on various cloud platforms, alongside SingleStore DB, a distributed SQL database suitable for both bare metal and hybrid cloud environments. The company focuses on operational analytics and supports modern data platform solutions that encompass IoT analytics, risk management, and customer engagement. SingleStore serves a diverse range of industries, including financial services, media communications, energy and utilities, government, and retail. The company, previously known as MemSQL Inc., rebranded to SingleStore, Inc. in October 2020 and also maintains offices in Seattle, Boston, Portland, Lisbon, and London.

Lookout

Series E in 2013
Lookout, Inc. is a cybersecurity company specializing in cloud-based technology solutions for mobile security. Founded in 2005 and headquartered in San Francisco, California, with additional offices in major cities worldwide, Lookout offers a range of products including mobile security apps for both Android and iOS devices. Its solutions encompass Mobile Threat Protection, a Mobile Intelligence Center for real-time threat investigations, and an App Vetting API designed to secure enterprise and commercial app stores. By providing organizations with tools to enable bring-your-own-device (BYOD) policies, ensure compliance, and combat advanced mobile threats, Lookout empowers enterprises and individuals to safeguard their sensitive data across devices, applications, networks, and clouds. The company's platform is trusted by various enterprises, government agencies, and millions of consumers, allowing them to manage their data securely and efficiently.

Quantopian

Series A in 2013
Quantopian, Inc. operates an online platform designed for the development and testing of quantitative trading algorithms. Founded in 2011 and based in Boston, Massachusetts, the platform offers tools and infrastructure that allow users to learn about quantitative finance, engage in community discussions, and explore algorithms shared by other members. Users can create and backtest their algorithms, review performance results and risk metrics, and trade their strategies. The company boasts a community of approximately 195,000 quants who collaborate and share insights. Additionally, select algorithm authors can license their algorithms to Quantopian, earning compensation based on performance. The firm provides capital, data, and resources to support its community in researching, coding, and executing algorithmic investing strategies.

GreenLight Biosciences

Series A in 2013
GreenLight Biosciences, Inc. is a biotechnology company that specializes in developing RNA-based solutions for agricultural and pharmaceutical applications. Headquartered in Medford, Massachusetts, with an additional facility in North Carolina, the company focuses on producing high-quality RNA quickly and cost-effectively. GreenLight's technology platform facilitates the biological conversion of renewable substrates into valuable products, including chemicals and fuels. The company is actively involved in advancing vaccine development, particularly mRNA-based candidates aimed at preventing diseases such as SARS-CoV-2. Additionally, GreenLight engages in crop management and plant protection initiatives, contributing to sustainable agricultural practices and supporting the health of pollinators. Through its innovative approaches, GreenLight Biosciences aims to address global challenges in food security and public health.

Ambri

Series B in 2012
Ambri, Inc. is a company based in Marlborough, Massachusetts, focused on developing innovative electricity storage solutions through its liquid metal battery technology. Founded in 2010 and originally known as Liquid Metal Battery Corporation, Ambri aims to revolutionize grid-scale power storage by offering batteries that are low-cost, long-lasting, and capable of storing significant amounts of energy. These batteries are particularly suited for applications in renewable energy systems and grid stabilization. Ambri's technology is designed to enhance the reliability and efficiency of energy storage, with systems that can tolerate short circuits and other operational challenges, making them a robust choice for grid operators.

Lookout

Series C in 2010
Lookout, Inc. is a cybersecurity company specializing in cloud-based technology solutions for mobile security. Founded in 2005 and headquartered in San Francisco, California, with additional offices in major cities worldwide, Lookout offers a range of products including mobile security apps for both Android and iOS devices. Its solutions encompass Mobile Threat Protection, a Mobile Intelligence Center for real-time threat investigations, and an App Vetting API designed to secure enterprise and commercial app stores. By providing organizations with tools to enable bring-your-own-device (BYOD) policies, ensure compliance, and combat advanced mobile threats, Lookout empowers enterprises and individuals to safeguard their sensitive data across devices, applications, networks, and clouds. The company's platform is trusted by various enterprises, government agencies, and millions of consumers, allowing them to manage their data securely and efficiently.

Lookout

Series B in 2010
Lookout, Inc. is a cybersecurity company specializing in cloud-based technology solutions for mobile security. Founded in 2005 and headquartered in San Francisco, California, with additional offices in major cities worldwide, Lookout offers a range of products including mobile security apps for both Android and iOS devices. Its solutions encompass Mobile Threat Protection, a Mobile Intelligence Center for real-time threat investigations, and an App Vetting API designed to secure enterprise and commercial app stores. By providing organizations with tools to enable bring-your-own-device (BYOD) policies, ensure compliance, and combat advanced mobile threats, Lookout empowers enterprises and individuals to safeguard their sensitive data across devices, applications, networks, and clouds. The company's platform is trusted by various enterprises, government agencies, and millions of consumers, allowing them to manage their data securely and efficiently.

Lookout

Series A in 2009
Lookout, Inc. is a cybersecurity company specializing in cloud-based technology solutions for mobile security. Founded in 2005 and headquartered in San Francisco, California, with additional offices in major cities worldwide, Lookout offers a range of products including mobile security apps for both Android and iOS devices. Its solutions encompass Mobile Threat Protection, a Mobile Intelligence Center for real-time threat investigations, and an App Vetting API designed to secure enterprise and commercial app stores. By providing organizations with tools to enable bring-your-own-device (BYOD) policies, ensure compliance, and combat advanced mobile threats, Lookout empowers enterprises and individuals to safeguard their sensitive data across devices, applications, networks, and clouds. The company's platform is trusted by various enterprises, government agencies, and millions of consumers, allowing them to manage their data securely and efficiently.

Lumenz

Venture Round in 2008
LumenZ, Inc is a Boston-based opto-electronic and efficient LED company. If you have any further information about this company, please build out the profile by clicking [here](/organization/lumenz-in/edit_overview).
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.